Insider Trading
5 articles in this category
SemiconductorsInsider TradingFundamental Analysis
ALAB 21-Day Outlook: Insider Selling and Margin Pressures Signal Downside Risk (Confidence: 6/10)
Despite strong historical revenue growth, massive insider selling and looming margin compression from elevated R&D costs point to a near-term price decrease.
ALAB
Read moreEarningsAnalyst RatingsInsider Trading
10x Genomics (TXG) Faces Mixed Signals Amid Insider Selling and Improving Cash Flows: 21-Day Sideways Outlook
Despite narrowing net losses and positive free cash flow, recent insider selling and a 20% weekly price drop suggest TXG will consolidate sideways.
TXG
Read more